Naringin, trimetazidine and baroreflex in renal ischemia-reperfusion injury

Página do item simplificado
dc.contributor.authorMartin, Luis Cuadrado [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2022-04-28T19:44:34Z
dc.date.available2022-04-28T19:44:34Z
dc.date.issued2021-01-01
dc.description.affiliationUniversidade Estadual Paulista
dc.description.affiliationUnespUniversidade Estadual Paulista
dc.format.extent298-299
dc.identifierhttp://dx.doi.org/10.36660/abc.20210453
dc.identifier.citationArquivos Brasileiros de Cardiologia, v. 117, n. 2, p. 298-299, 2021.
dc.identifier.doi10.36660/abc.20210453
dc.identifier.issn1678-4170
dc.identifier.issn0066-782X
dc.identifier.scopus2-s2.0-85114856555
dc.identifier.urihttp://hdl.handle.net/11449/222404
dc.language.isoeng
dc.language.isopor
dc.relation.ispartofArquivos Brasileiros de Cardiologia
dc.sourceScopus
dc.subjectFlavanones
dc.subjectFlavonoids
dc.subjectHeart failure
dc.subjectHypertension
dc.subjectOxidative stress
dc.subjectRenal reperfusion
dc.subjectTrimetazidine
dc.subjectVasodilatador agents
dc.titleNaringin, trimetazidine and baroreflex in renal ischemia-reperfusion injuryen
dc.titleNaringina, trimetazidina e barorreflexo na lesão de isquemia e reperfusão renalpt
dc.typeEditorial

Arquivos

Coleções

Artigos